Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases

Overview of attention for article published in Cardiovascular Diabetology, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 29 X posts from 25 X users, with an upper bound of 87,355 followers.

RT @Biomaven: @EricTopol @TheLancetEndo Note the very potent Japanese statin, pitavastatin, (approved in the US, should be generic here soo…

@EricTopol @TheLancetEndo Note the very potent Japanese statin, pitavastatin, (approved in the US, should be generic here soon) seems to be different: https://t.co/YpwR73nz6O

RT @drlaurajwaters: With all the chat about @reprievetrial at #IAS2023 including concerns about diabetes risk, I thought this network cohor…

RT @drlaurajwaters: With all the chat about @reprievetrial at #IAS2023 including concerns about diabetes risk, I thought this network cohor…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 25 additional X posts.